Valsartan Jubilant Filmuhúðuð tafla 80 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

valsartan jubilant filmuhúðuð tafla 80 mg

jubilant pharmaceuticals nv - valsartanum inn - filmuhúðuð tafla - 80 mg

Enalapril Krka Tafla 10 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

enalapril krka tafla 10 mg

krka sverige ab - enalaprilum maleat - tafla - 10 mg

Enalapril Krka Tafla 2,5 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

enalapril krka tafla 2,5 mg

krka sverige ab - enalaprilum maleat - tafla - 2,5 mg

Valpress Filmuhúðuð tafla 160 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

valpress filmuhúðuð tafla 160 mg

teva b.v.* - valsartanum inn - filmuhúðuð tafla - 160 mg

Valpress Filmuhúðuð tafla 80 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

valpress filmuhúðuð tafla 80 mg

teva b.v.* - valsartanum inn - filmuhúðuð tafla - 80 mg

Valsartan Jubilant Filmuhúðuð tafla 160 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

valsartan jubilant filmuhúðuð tafla 160 mg

jubilant pharmaceuticals nv - valsartanum inn - filmuhúðuð tafla - 160 mg

Valsartan Krka Filmuhúðuð tafla 80 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

valsartan krka filmuhúðuð tafla 80 mg

krka sverige ab - valsartanum inn - filmuhúðuð tafla - 80 mg

Entresto الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - hjartabilun - ace ii hemla, önnur sturtu, umboðsmenn starfa á renín-ace kerfi - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG) الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

kinzalmono (previously telmisartan boehringer ingelheim pharma kg)

bayer ag - telmisartan - háþrýstingur - lyf sem hafa áhrif á renín-angíótensín kerfið - hypertensiontreatment háþrýstingi í fullorðnir. hjarta preventionreduction á hjarta dánar í sjúklinga með:vart atherothrombotic hjarta sjúkdómur (sögu hjarta sjúkdómur, heilablóðfall, eða útlæga slagæð sjúkdómur) eða;tegund-2 sykursýki með skjalfest miða-líffæri.

Micardis الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

micardis

boehringer ingelheim international gmbh - telmisartan - háþrýstingur - angíótensín ii blokkar, látlaus - hypertensiontreatment háþrýstingi í fullorðnir. hjarta preventionreduction á hjarta dánar í sjúklinga með:vart atherothrombotic hjarta sjúkdómur (sögu hjarta sjúkdómur, heilablóðfall, eða útlæga slagæð sjúkdómur) eða;tegund-2 sykursýki með skjalfest miða-líffæri.